Emergent BioSolutions (EBS) Tops Q3 EPS by 32c; Says FY16 Outlook Still Postponed

Go back to Emergent BioSolutions (EBS) Tops Q3 EPS by 32c; Says FY16 Outlook Still Postponed
EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) Delayed: 5.72 -0.28 (4.67%)
Previous Close $6.00    52 Week High $44.38 
Open $5.96    52 Week Low $24.47 
Day High $6.04    P/E 286.00 
Day Low $5.61    EPS $0.02 
Volume 824,552